Form 4 for DYN Dyne Therapeutics, Inc.
Accepted 2024-09-10 00:00:00 ET · period of report 2024-09-06 · accession 0000950170-24-105123 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-09-10 | 2024-09-06 | DYN | Scalzo Richard William | SVP, Head of Fin, Admin | M - OptEx | $12.56 | +116.5K | 117.5K | +11,136% | +$1.46M |
| DM | 2024-09-10 | 2024-09-06 | DYN | Scalzo Richard William | SVP, Head of Fin, Admin | S - Sale+OE | $32.15 | -126.1K | 103.1K | -55% | -$4.05M |
| DM | 2024-09-10 | 2024-09-06 | DYN | Scalzo Richard William | SVP, Head of Fin, Admin | M - OptEx | $0.00 | -116.5K | 742 | -99% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-06 | M | A | 6,552 | $10.88 | 227,500 | D | — | — | (F1) Includes 101,426 unvested RSUs. |
| 2 | Common | Common Stock | 2024-09-06 | M | A | 18,750 | $10.72 | 220,948 | D | — | — | (F1) Includes 101,426 unvested RSUs. |
| 3 | Common | Common Stock | 2024-09-06 | S | D | 1,700 | $32.63 | 101,426 | D | — | — | (F1) Includes 101,426 unvested RSUs. |
| 4 | Common | Common Stock | 2024-09-06 | S | D | 124,374 | $32.14 | 103,126 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $31.62 to $32.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote of this Form 4. (F1) Includes 101,426 unvested RSUs. |
| 5 | Common | Common Stock | 2024-09-06 | M | A | 29,792 | $8.58 | 202,198 | D | — | — | (F1) Includes 101,426 unvested RSUs. |
| 6 | Common | Common Stock | 2024-09-06 | M | A | 3,353 | $5.54 | 120,877 | D | — | — | (F1) Includes 101,426 unvested RSUs. |
| 7 | Common | Common Stock | 2024-09-06 | M | A | 34,833 | $19.00 | 155,710 | D | — | — | (F1) Includes 101,426 unvested RSUs. |
| 8 | Common | Common Stock | 2024-09-06 | M | A | 16,696 | $13.12 | 172,406 | D | — | — | (F1) Includes 101,426 unvested RSUs. |
| 9 | Common | Common Stock | 2024-09-06 | M | A | 6,502 | $5.54 | 117,524 | D | — | — | (F1) Includes 101,426 unvested RSUs. |
| 10 | Derivative | Stock option (right to buy) | 2024-09-06 | M | D | 29,792 | $0.00 | 25,208 | D | $8.58 · — to 2032-07-10 | 29,792 Common Stock | (F7) The option was granted on July 11, 2022. The shares underlying the option vest over four years in equal monthly installments beginning on July 1, 2022. |
| 11 | Derivative | Stock option (right to buy) | 2024-09-06 | M | D | 6,552 | $0.00 | 28,394 | D | $10.88 · — to 2033-11-14 | 6,552 Common Stock | (F9) The option was granted on November 15, 2023. The shares underlying the option vest over four years in equal monthly installments through November 15, 2027. |
| 12 | Derivative | Stock option (right to buy) | 2024-09-06 | M | D | 18,750 | $0.00 | 26,250 | D | $10.72 · — to 2032-12-08 | 18,750 Common Stock | (F8) The option was granted on December 9, 2022. The shares underlying the option vest over four years in equal monthly installments through December 10, 2026. |
| 13 | Derivative | Stock option (right to buy) | 2024-09-06 | M | D | 16,696 | $0.00 | 8,348 | D | $13.12 · — to 2031-12-09 | 16,696 Common Stock | (F6) The option was granted on December 10, 2021. The shares underlying the option vest over four years in equal monthly installments through December 10, 2025. |
| 14 | Derivative | Stock option (right to buy) | 2024-09-06 | M | D | 6,502 | $0.00 | 0 | D | $5.54 · — to 2030-07-30 | 6,502 Common Stock | (F3) The option was granted on July 31, 2020. The shares underlying the option vest over four years in equal quarterly installments through July 31, 2024, provided that no shares shall vest prior to December 2, 2020. |
| 15 | Derivative | Stock option (right to buy) | 2024-09-06 | M | D | 3,353 | $0.00 | 0 | D | $5.54 · — to 2030-07-30 | 3,353 Common Stock | (F4) The option was granted on July 31, 2020. The shares underlying the option vest over four years in equal quarterly installments through July 31, 2024, provided that no shares shall vest prior to December 2, 2020. |
| 16 | Derivative | Stock option (right to buy) | 2024-09-06 | M | D | 34,833 | $0.00 | 742 | D | $19.00 · — to 2030-09-15 | 34,833 Common Stock | (F5) The option was granted on September 16, 2020. The shares underlying the option vest over four years in equal monthly installments through September 16, 2024. |